QGAI (Quantum Genesis AI) 3-Year EBITDA Growth Rate: 81.30% (As of Apr. 2026) — 15% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Quantum Genesis AI 3-Year EBITDA Growth Rate?

Quantum Genesis AI QGAI -15.00% 3-Year EBITDA Growth Rate is 81.30% as of Apr. 2026, which is 15% above its 10-year median of 70.80. The stock has 2 warning signs investors should review. Among 1,414 Chemicals companies, Quantum Genesis AI ranks better than 97.74% on this metric.

Quantum Genesis AI's EBITDA per Share for the three months ended in Apr. 2026 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 81.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Quantum Genesis AI was 81.30% per year. The lowest was 60.30% per year. And the median was 70.80% per year.


Quantum Genesis AI  (OTCPK:QGAI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Quantum Genesis AI 3-Year EBITDA Growth Rate Related Terms


QGAI vs BGLC, CNEY, TSEOQ: 3-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, Quantum Genesis AI's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum Genesis AI 3-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Quantum Genesis AI's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Quantum Genesis AI's 3-Year EBITDA Growth Rate falls into.



Quantum Genesis AI 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 81.30% mean?
Quantum Genesis AI (QGAI) has a 3-Year EBITDA Growth Rate of 81.30% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quantum Genesis AI and its competitors. This is 15% above median its historical median of 70.80. Over the past decade, Quantum Genesis AI's 3-Year EBITDA Growth Rate has ranged from 60.30 to 81.30. According to the industry distribution chart, Quantum Genesis AI ranks #32 out of 1414 companies in the Chemicals industry, placing it in the top 2.3%.
Is Quantum Genesis AI's 3-Year EBITDA Growth Rate too high?
Quantum Genesis AI's current 3-Year EBITDA Growth Rate of 81.30% is 15% above median its 10-year median of 70.80. Over the past 10 years, this metric has ranged from a low of 60.30 to a high of 81.30. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.70. Quantum Genesis AI's value of 81.30% is 11514.3% above this industry median. Based on the distribution chart, Quantum Genesis AI ranks #32 out of 1414 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers.
How does Quantum Genesis AI's 3-Year EBITDA Growth Rate compare to BGLC and CNEY?
According to the Chemicals industry distribution chart, Quantum Genesis AI ranks #32 out of 1414 companies for 3-Year EBITDA Growth Rate. This places Quantum Genesis AI in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.70. Quantum Genesis AI's value of 81.30% is 11514.3% above this benchmark. Historically, Quantum Genesis AI's own 3-Year EBITDA Growth Rate has ranged from 60.30 to 81.30 over the past decade. While the company's 10-year median is 70.80 vs. the industry median of 0.70, Quantum Genesis AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.70, based on 1,414 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quantum Genesis AI's current 3-Year EBITDA Growth Rate of 81.30% is 11514.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quantum Genesis AI and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quantum Genesis AI's current 3-Year EBITDA Growth Rate is 81.30%, which is 15% above median its own 10-year median of 70.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Genesis AI stock overvalued right now?
Quantum Genesis AI (QGAI) has a current 3-Year EBITDA Growth Rate of 81.30%. The current 3-Year EBITDA Growth Rate is 81.30%, which is 15% above median its 10-year median of 70.80 and 11514.3% above the Chemicals industry median of 0.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Quantum Genesis AI (QGAI), the current 3-Year EBITDA Growth Rate is 81.30% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum Genesis AI Business Description

Address 15656 Bernardo Center Drive, Suite 801, San Diego, CA, USA, 92127
Quantum Genesis AI Corp, formerly Quantumzyme Corp is a biotransformation company. The company specializes in clean and green chemistry solutions. The company utilizes customer-centric research to enhance enzyme activity, selectivity, and specificity by applying novel quantum mechanics, molecular modeling, and engineering approaches.